Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry.
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology"
DOI: 10.1093/rheumatology/kez577
Abstract: OBJECTIVE Using data from the German Biologics JIA Registry (BIKER), long-term safety of biologics for systemic-onset JIA with regard to adverse events of special interest was assessed. METHODS Safety assessments were based on adverse event… read more here.
Keywords: biker; long term; systemic onset; data german ... See more keywords
SAT0502 EFFICACY AND SAFETY OF ADALIMUMAB IN JUVENILE IDIOPATHIC ARTHRITIS – 10 YEAR EXPERIENCE USING DATA OF THE BIKER REGISTRY
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.1457
Abstract: Background Since 2008, Adalimumab is approved for polyarticular juvenile idiopathic arthritis (JIA) and approval has been extended to other JIA categories and for uveitis. Objectives To evaluate efficacy and safety of Adalimumab in clinical practice… read more here.
Keywords: biker; none declared; jia; safety ... See more keywords
FRI0560 EFFICACY AND SAFETY OF ANAKINRA IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS – DATA OF THE BIKER REGISTRY
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.2608
Abstract: Background Anakinra (ANA) is recommended for treatment of systemic juvenile idiopathic arthritis (sJIA) and has recently received EMA approval. Objectives To describe safety and effectiveness of ANA in clinical practice in sJIA patients documented in… read more here.
Keywords: none; systemic juvenile; none declared; biker ... See more keywords